Zhangwei Chen1, You Zhou2, Jiasheng Yin1, Qinglai Gao3, Ao Chen1, Yan Xia1, Danbo Lu1, Dong Huang1, Juying Qian1, Junbo Ge1. 1. Department of Cardiology, Zhongshan Hospital, Fudan University, Shanghai Institute of Cardiovascular Diseases, National Clinical Research Center for Interventional Medicine, Shanghai 200032, China. 2. Department of Cardiology, Zhongshan Hospital, Fudan University, Shanghai Geriatric Medical Center, Shanghai Institute of Cardiovascular Diseases, National Clinical Research Center for Interventional Medicine, Shanghai 200032, China. 3. Department of Cardiology, People's Hospital of Wulian, Rizhao, Shangdong Province 262300, China.
Abstract
BACKGROUND: Periprocedural myocardial injury (PMI) is a most common complication of percutaneous coronary intervention (PCI). Microembolization and inflammation underlying PMI could lead to coronary microvascular dysfunction (CMD) and vice versa. Reactive hyperemia index (RHI) assessed by peripheral artery tonometry (PAT) has been considered as a noninvasive method to assess endothelial function and CMD, which could be useful to predict PMI. METHODS: 268 patients suspected with stable coronary artery disease (CAD) and scheduled for elective coronary angiography were enrolled. RHI was measured by using the Endo-PAT2000™ device before angiography. The association among RHI, PMI, and cardiovascular events was further assessed. RESULTS: In this cohort, 189 patients (70.5%) were diagnosed with CAD and 119 patients (44.4%) underwent drug-eluting stent (DES) implantation. Compared with patients without CAD, CAD patients had lower RHI (1.88 ± 0.55 vs. 2.02 ± 0.58, P < 0.05). Patients with PMI had a lower RHI before angiography (1.75 ± 0.37 vs. 1.95 ± 0.50, P < 0.05). Receiver operating characteristic curve analysis of RHI revealed an area under the curve (AUC) of 0.61, with a sensitivity of 62.7% and specificity of 50.0% to predict PMI. Moreover, we found that CAD patients with RHI ≤ 1.81 had a higher incidence of composite cardiac events after stenting (adjusted hazard ratio (HR) 3.31, 95% confidence interval (CI) 1.07-10.22, P < 0.05). CONCLUSIONS: RHI assessment through PAT could be a promising method to predict PMI before the procedure. RHI is associated with increased risk of long-term adverse cardiac events after DES implantation.
BACKGROUND: Periprocedural myocardial injury (PMI) is a most common complication of percutaneous coronary intervention (PCI). Microembolization and inflammation underlying PMI could lead to coronary microvascular dysfunction (CMD) and vice versa. Reactive hyperemia index (RHI) assessed by peripheral artery tonometry (PAT) has been considered as a noninvasive method to assess endothelial function and CMD, which could be useful to predict PMI. METHODS: 268 patients suspected with stable coronary artery disease (CAD) and scheduled for elective coronary angiography were enrolled. RHI was measured by using the Endo-PAT2000™ device before angiography. The association among RHI, PMI, and cardiovascular events was further assessed. RESULTS: In this cohort, 189 patients (70.5%) were diagnosed with CAD and 119 patients (44.4%) underwent drug-eluting stent (DES) implantation. Compared with patients without CAD, CAD patients had lower RHI (1.88 ± 0.55 vs. 2.02 ± 0.58, P < 0.05). Patients with PMI had a lower RHI before angiography (1.75 ± 0.37 vs. 1.95 ± 0.50, P < 0.05). Receiver operating characteristic curve analysis of RHI revealed an area under the curve (AUC) of 0.61, with a sensitivity of 62.7% and specificity of 50.0% to predict PMI. Moreover, we found that CAD patients with RHI ≤ 1.81 had a higher incidence of composite cardiac events after stenting (adjusted hazard ratio (HR) 3.31, 95% confidence interval (CI) 1.07-10.22, P < 0.05). CONCLUSIONS: RHI assessment through PAT could be a promising method to predict PMI before the procedure. RHI is associated with increased risk of long-term adverse cardiac events after DES implantation.
Authors: Luisa Gregorini; Jean Marco; Bruno Farah; Monique Bernies; Carlo Palombo; Michaela Kozàkovà; Irene M Bossi; Bernard Cassagneau; Jean Fajadet; Carlo Di Mario; Remo Albiero; Massimo Cugno; Adalberto Grossi; Gerd Heusch Journal: Circulation Date: 2002-12-03 Impact factor: 29.690
Authors: Enrico Vizzardi; Mara Gavazzoni; Paolo Della Pina; Ivano Bonadei; Valentina Regazzoni; Edoardo Sciatti; Eleftheria Trichaki; Riccardo Raddino; Marco Metra Journal: J Investig Med Date: 2014-08 Impact factor: 2.895
Authors: Diana Bonderman; Alexander Teml; Johannes Jakowitsch; Christopher Adlbrecht; Mariann Gyöngyösi; Wolfgang Sperker; Harald Lass; Wilhelm Mosgoeller; Dietmar H Glogar; Peter Probst; Gerald Maurer; Yale Nemerson; Irene M Lang Journal: Blood Date: 2002-04-15 Impact factor: 22.113
Authors: Piero O Bonetti; Geralyn M Pumper; Stuart T Higano; David R Holmes; Jeffrey T Kuvin; Amir Lerman Journal: J Am Coll Cardiol Date: 2004-12-07 Impact factor: 24.094
Authors: Hanan Idris; Sidney Lo; Ibrahim M Shugman; Yousef Saad; Andrew P Hopkins; Christian Mussap; Dominic Leung; Liza Thomas; Craig P Juergens; John K French Journal: J Am Heart Assoc Date: 2014-10-30 Impact factor: 5.501